In Canada, GLP-1 medications are already a significant driver of drug plan spending an Alberta Blue Cross report that reviewed new drug and supplemental submissions made to Health Canada in 2025 named such treatments as a major cost of employer-sponsored drug plans, particularly as the drugs are approved for treatment of more conditions
The primary concern is not pharmacokinetic interaction but rather the gastrointestinal effects of semaglutide potentially altering the absorption of oral HRT medications
doi:10.1080/08998280.2006.11928181
In response, your body redirects energy and nutrients toward essential survival functions and away from processes it considers less critical, including hair growth
10.5772/48189 23 GovaertsR
Understanding that small air bubbles can be normal helps reduce unnecessary anxiety, but it's important to follow the specific Instructions for Use (IFU) provided with your particular GLP-1 device, as handling procedures vary between different products